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Background: Stagnating funds for malaria control have spurred interest in the question of how to sustain the gains
of recent successes with long-lasting insecticidal nets (LLINs) and improved case management (CM). This simulation
study examined the malaria transmission and disease dynamics in scenarios with sustained LLINs and CM
interventions and tried to determine optimal LLIN distribution rates. The effects of abruptly halting LLIN distribution
were also examined.
Methods: Dynamic simulations of malaria in humans and mosquitoes were run on the OpenMalaria platform, using
stochastic individual-based simulation models. LLINs were distributed in a range of transmission settings, with
varying CM coverage levels.
Results: In the short-term, LLINs were beneficial over the entire transmission spectrum, reducing both transmission
and disease burden. In the long-term, repeated distributions sustainably reduced transmission in all settings.
However, because of the resulting reduction in acquired immunity in the population, the malaria disease burden,
after initially being reduced, gradually increased and eventually stabilized at a new level. This new level was higher
than the pre-intervention level in previously high transmission settings, if there is a maximum disease burden in the
relationship between transmission and disease burden at intermediate transmission levels. This result could lead
one to conclude that sustained LLIN distribution might not be cost-effective in high transmission settings in the
long term. However, improved CM rendered LLINs more cost-effective in higher transmission settings than in those
without improved CM and the majority of the African population lives in areas where CM and LLINs are sustainably
combined. The effects of changes in LLIN distribution rate on cost-effectiveness were relatively small compared to
the effects of changes in transmission setting and CM. Abruptly halting LLIN distribution led to temporary morbidity
peaks, which were particularly large in low to intermediate transmission settings.
Conclusions: This study reaffirms the importance of context specific intervention planning. Intervention planning
must include combinations of malaria vector control and CM, and must consider both the pre-intervention
transmission level and the intervention history to account for the loss of immunity and the potential for rebounds
in disease burden.
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Sustaining the gains of recent malaria control successes,
primarily achieved with long-lasting insecticidal nets
(LLINs) and improved case management (CM), is attract-
ing global interest. The current economic crisis has re-
sulted in, at best, stagnating funds for malaria control [1].
However, disbursements are increasingly needed to com-
pensate for reductions in acquired immunity —the result
of transmission reductions caused by the large-scale roll-
out of LLINs [2]. Rationally planning the most cost-
effective allocation of malaria control resources is both
urgent and complex.
Cost-effectiveness estimates of single malaria interven-
tions and intervention packages [3-7] often assume fixed
numbers of episodes and deaths averted per intervention
unit and do not account for malaria transmission dynamics,
or do so indirectly [8]. Dynamic models of malaria, such
as those deployed on the OpenMalaria modelling plat-
form [9], can capture the effects of reducing immunity in
the population on the cost-effectiveness of intervention
packages.
A previous analysis of LLINs in OpenMalaria [10] fo-
cused on the duration of the effective period (life time)
of a single mass distribution of long-lasting insecticidal
nets (LLINs) and studied its sensitivity to several param-
eters. The outcome variable analysed was the effective
period from the time of distribution until the impact
had reduced to half of its maximum. The reasoning was
that at half impact, it would be wise to distribute more
nets to compensate for the lost nets and sustain impact.
That study [10] also showed that under a hypothetical
situation with sustained LLIN coverage, without attrition
or decay, the number of episodes would rebound
(despite the sustained coverage) to a new equilibrium
level. This was presumably due to reduced acquisition of
immunity in the population. In high transmission situa-
tions, the new equilibrium level of disease burden was
often higher than the burden before LLIN implementa-
tion, even though transmission was reduced. These results
are consistent with the findings of Marsh and Snow [11],
that in areas of high transmission, altering immunity pro-
files via interventions could lead to increased malaria bur-
den if not accompanied with improved case management.
Building on the analysis of LLINs [10], this paper
addresses four issues: firstly, the sustainability of health
benefits from repeated mass distributions and continuous
distribution of LLINs over longer time periods, taking attri-
tion and decay into account; secondly, the sensitivity of the
expected health benefits to transmission and distribution
parameters; thirdly, how this interacts with the probability
of treating malarial episodes, i.e. the case management
(CM) level; finally, the potential consequences of halting
LLIN distribution abruptly after an extended period of re-
peated mass distributions and continuous distributions.Methods
A simulation experiment was set up in OpenMalaria, simi-
lar to the one described previously by Briët and colleagues
[10]. Briefly, the OpenMalaria modelling platform [9] is an
open source programme in which stochastic individual-
based models for malaria in humans are combined with a
deterministic model for malaria in mosquitoes. Fourteen
different model variants were used, each based on differ-
ent assumptions [12]. Each simulated malaria infection
has a distinct parasite density that varies by a five-day time
step, while the malaria transmission level varies seasonally.
In previous work [10], values of key parameters were
varied around a “central scenario”, where 70% of a simu-
lated population of 10,000 individuals received an LLIN
that decayed over time. In this previous work, the main
outcome of measuring impact was episodes averted.
Here, in addition to events averted, the impact on both
transmission and disability adjusted life years (DALYs)
due to malaria is analysed.
In order to investigate the health benefits from repeated
mass distributions and continuous distribution of LLINs
in economic terms, this paper uses net health benefits
(NHB) [13] as an economic outcome. The NHB are
expressed in DALYs due to malaria, where malaria related
deaths form by far the largest component. The costs and
cost savings to the health system are also included in this
statistic, using a ceiling ratio conversion factor of USD
235.28 2012 per DALY. The method for calculating DALYs
and NHB is described by Briët and colleagues [14]. In the
literature, incremental cost-effectiveness ratios (ICERs) are
often used to quantify cost-effectiveness of interventions
such as LLINs [7], instead of NHB. ICERs have the disad-
vantage of being very large or very small when cases,
deaths or DALYs averted are just above or below zero,
respectively. Thus, they are not suitable for describing
cost-effectiveness in situations where the effectiveness of
interventions may be small, such as encountered here [see
Additional file 1]. Impact on episodes, DALYs and NHB
were calculated for both the whole population and for
children less than five years of age.
For this experiment, the central scenario [described in
Additional file 2] was identical to that used previously
[10], except for the following differences:
i) The population size was 100,000 instead of 10,000 to
account for stochasticity in rare events (deaths),
necessary for DALY calculation.
ii) The accessible population proportion was set at 90%
instead of 100%. This means that 10% of the
population never received an LLIN, reflecting the
reality that some people are out of reach of distribution
campaigns for geographic or other reasons.
iii) Instead of a single mass distribution (five years into
the simulation), mass distributions (to 70% of the
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years to recipients at random, irrespective of having
(had) access to a net in a previous distribution.
iv) The simulation was extended to last 125 years
v) Eighty per cent of accessible new-borns and their
mothers received access to (the use of ) a new net
through continuous distribution [15].
vi) The mosquito population had a susceptibility (to
LLINs) profile as described [14] for the population
‘Pitoa’ to LLIN Permanet 2.0. This population showed
70% mortality in a 0.05% deltamethrin World Health
Organization (WHO) cylinder / tube susceptibility
test [16] and, in the absence of LLINs, 75% of
mosquito-human contact occurred during times when
people were sleeping indoors at night, while 25%
occurred during other times [17]. Two assumptions
were made: first, that mosquitoes repeated their host
searching behaviour every feeding cycle [17] and
second, that when someone already using an LLIN
received a new one, the old one was discarded.
In addition to the changes listed above, several other
outcome variables were monitored to calculate NHB. To
analyse the sensitivity of NHB to changes in the model’s
transmission and distribution parameters, the following
variations of the central scenario were included:
i) Fourteen model variants, each differing in their
assumptions about malaria epidemiology [12];
ii) Nine levels of pre-intervention entomological
inoculation rates (EIR), at 1, 2, 4, 8, 16, 32, 64, 128
and 256 infectious bites per adult per annum
(IBPAPA);
iii) Mosquito insecticide susceptibility profiles of
highly resistant (population ‘Akron’ [18]) and
susceptible populations (population ‘Zeneti’[19]), in
addition to the intermediate ‘Pitoa’ population;
iv) LLIN attrition half-lives of three and five years, in
addition to the four years used in the central scenario;
v) Distribution round intervals of three and five years,
as well as the four years used in the central scenario;
vi) Distribution round coverage levels of 60 and 80%,
in addition to the 70% used in the central scenario,
of the accessible population (90% of the total
human population);
vii) Continuous coverage levels at birth of 0%, 70%,
80% (central scenario) and 90%, as well as a double
net distribution at 80%, approximating the effects
of continuous net distribution both through
antenatal campaigns (ANC) and through the
Expanded Programme on Immunization (EPI).
viii) For uncomplicated malaria episodes, five-day
treatment probabilities of 0.05 [20,21] (baseline in
the central scenario), 0.23712 and 0.4256. The five-day treatment probability of 0.05 corresponds to a
level of 9% reported treatment of recalled fevers with
an effective antimalarial drug in Demographic and
Health Surveys (DHS) and Malaria Indicator Surveys
(MIS) [22]. The five-day treatment probability of
0.2371 corresponds to a 2010 Tanzanian DHS level
of reported treatment of recalled fevers of 59%
[23]. The five-day treatment probability of 0.4256
corresponds to a level of reported treatment of
recalled fevers of 80%. This is lower than Roll Back
Malaria’s 2010 target of 80% of cases treated with
effective anti-malarial medicines within one day of
the onset of illness [24]. Due to recall bias, the true
proportion of treated cases will be lower than the
recalled proportion (fevers that are not treated are
less often reported), and a proportion of fevers are
not treated within one day of onset. Simulations used
the baseline CM level corresponding to 9% treatment
levels during the simulations’ warm up phase, and if
scaled up, this was done automatically five years into
the simulation. Health system costs were based on a
fixed cost per treatment [25] and the cost of scaling
up CM capacity (e.g. building extra health facilities) or
behavioural change communication was not included.
For severe malaria in hospital, the five-day treatment
probability was kept constant at 48% [20].
ix) LLIN distribution halted after 32 years (37 years
into the simulation, after eight rounds of mass
distributions every four years, supplemented with
continuously distributed LLINs). This was done to
assess how a sudden breakdown in LLIN
distribution programmes would affect the malaria
burden in areas where acquired immunity had been
reduced substantially.
Results and discussion
Dynamics of malaria with continued interventions
Figure 1 shows the effects of distributing LLINs on malaria
in the whole population (central scenario). These plots
show the simulated EIR, episodes and DALYs relative to a
non-intervention scenario for the first 60 years of the
simulation, depending on pre-intervention EIR and model
variant. All three outcomes declined sharply after LLIN
distribution was initiated and rebounded to a new periodic
stable state. The higher the pre-intervention transmission
level, the faster the periodic stable state was reached. This
is consistent with the observation in randomized con-
trolled trials of insecticide treated nets (ITNs) that pro-
tective efficacy is reduced during the second year
compared to the first year in areas of high transmission,
but not in areas of low to moderate transmission [26]. For
EIR, the new periodic stable state was only slightly higher
than the lowest level reached (the median difference in the
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Figure 1 Impact of LLINs on EIR, episodes and DALYs over time. Green lines show medians and red polygons show ranges over 10 runs
with unique seeds, of 14 model variants, of the ratio of the outcome variable in the intervention scenario relative to in the reference scenario
(without intervention). a – d) entomological inoculation rate (EIR), e – g) episodes and i – l) disability adjusted life years (DALYs). Rows of panels
have the same pre-intervention EIR.
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However, the rebound was important for episodes (a me-
dian difference of 0.25) and DALYs (a median difference
of 0.19) and varied with the pre-intervention transmission
level. Versions of this figure and all following figures for
outcomes calculated for children under five years of age
only (instead of for the entire population) are presented in
Additional file 3.
The effects of scaling up CM to a level of 80% reported
treatment of recalled fevers, compared to no intervention
(with CM continued at a low level of 9% reported treat-
ment of recalled fevers), are shown as ratios of outcomes
(EIR, episodes, DALYs) per person year in Figure 2. These
scenarios did not include LLIN distribution. At low and
intermediate pre-intervention EIR levels, there was strong
variability among the results from model variants, espe-
cially in terms of impact on the EIR. This variability is
caused by differences among model variants in the rela-
tionship between prevalence of infectious people and EIR,
depending on the level of access to care. Model variantsR0063, R0065 and R0068 included heterogeneity in trans-
mission; across CM levels, these model variants showed
little variation in the proportion of bites on humans that
are infectious to mosquitoes [see Additional file 4]. These
model variants are represented by the highest curves in
Figure 2a – d. In contrast, model variants R0115, R0125,
R0132 and R0133 modelled quick decay of immunity;
across CM levels, these model variants show a strong vari-
ation in the proportion of bites on humans that are infec-
tious to mosquitoes. These model variants are represented
by the lowest curves in Figure 2a – d. For a setting with a
pre-intervention EIR of four IBPAPA, EIR, episodes and
DALYs decreased strongly and then more or less plat-
eaued, increased slightly or continued to decline,
depending on the model variant. At higher pre-
intervention EIR levels, EIR and episodes decreased
slightly and slowly rebounded to a new level. DALYs, in
contrast, decreased much more strongly and quickly,
and then rebounded slightly but quickly to a new stable
state. Scaled-up CM had some effect on transmission at
Figure 2 Impact of scaled-up case management on EIR, episodes and DALYs over time. a – d) entomological inoculation rate (EIR), e – g)
episodes and i – l) disability adjusted life years (DALYs). Rows of panels have the same pre-intervention EIR.
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impact on transmission above an EIR of 64 IBPAPA. Simi-
larly, its impact on the incidence of malaria episodes was
negligible in such settings. The proportion of severe mal-
aria disease and malaria related deaths that was averted by
scaled-up management of uncomplicated malaria cases
was considerable, even in high transmission settings (Note
that treatment of severe malarial disease was not scaled-
up in these scenarios and remained constant at 48%).
The effects of both distributing LLINs and scaling up
CM to achieve a level of 80% reported treatment of
recalled fevers, compared to no intervention (apart from alow continued level of CM), are shown as ratios of out-
comes (EIR, episodes, DALYs) per person year in Figure 3.
For the EIR outcome (Figure 3a – 3d), these curves are
similar to those shown in corresponding panels in Figure 1.
For episodes (Figure 3e – 3h), the rebound was weaker in
the scenarios with combined intervention than in the
scenarios with LLIN distribution alone, especially in inter-
mediate transmission settings (Figure 3f and 3g). For
DALYs, at a pre-intervention EIR of 16 IBPAPA (Figure 3j),
the rebound was much smaller with combined inter-
vention than with either intervention alone. However,
at higher pre-intervention EIRs (Figure 3k and 3l), the
Figure 3 Impact of LLIN distributions and scaled-up case management on EIR, episodes and DALYs over time. a – d) entomological
inoculation rate (EIR), e – g) episodes and i – l) disability adjusted life years (DALYs). Rows of panels have the same pre-intervention EIR.
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lowered the level and repeated LLIN distributions
caused periodicity in the DALYs.
Figure 4 shows the temporal dynamics of NHB of both
LLINs and scaled-up CM expressed in DALYs, as com-
pared to scenarios without scaled-up CM. In contrast to
Figures 1, 2 and 3, where outcome variables are shown as
a ratio of the results in the non-intervention scenarios,
Figure 4 shows results in terms of an absolute difference.
In Figures 1, 2 and 3, a curve is below the line where ‘ratio
equals unity’ indicates a desired effect; in Figure 4, a curve
above the horizontal line of ‘zero NHB’ indicates a desiredeffect. Also, instead of graphing all 14 model variants, a
goodness of fit-weighted average of the model ensemble is
plotted. The small dip in the fifth year after the start of the
simulation (the red and black lines) is caused by the cost
of the first round of LLIN distributions, which was in-
curred in the last 5-day period of the fifth year.
In the low transmission setting of four IBPAPA pre-
intervention, the NHB of scaling up CM, of LLIN distri-
bution and of combining the two interventions took five
to 10 years to reach a maximum and declined slightly
thereafter. In the transmission setting of 16 IBPAPA
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Figure 4 Temporal dynamics of net health benefits of LLINs
and case management. Lines are goodness of fit-weighted averages
of the 14 variants in the model ensemble. Net health benefits are
calculated as compared to scenarios with a low baseline case
management (CM) of 9% reported treatment of recalled fevers with
an effective antimalarial drug in demographic health surveys or
similar surveys. Red lines show the effect of only distributing long
lasting insecticidal nets (LLINs). Green lines show the effect of only
scaling up CM to 80% reported treatment of recalled fevers. Black
lines show the effect of both distributing LLINs and scaling up CM
to 80%.
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IBPAPA, but the NHB of individual interventions peaked
earlier and declined steeply, particularly the NHB of
LLINs. In transmission settings of 64 and 256 IBPAPA
pre-intervention, the NHB of the combined intervention
also peaked early and declined steeply. The NHB of LLINs
alone were negative from the second round onward. NHB
are presented cumulatively over time in Additional file 5.
Figure 5 summarizes the results for EIR, episodes and
DALYs as ratios of mean periodic stable states. These
were calculated as averages over the last 60 years of the
125-year simulation runs. It was assumed that LLIN effi-
cacy was constant over time (thus not affected by vectorresistance to insecticides) and that there would be no
further changes to the health system (including the vec-
tor control programme) or to socio-economic condi-
tions. These assumptions may not be realistic, but the
summary (at the stable state) is not subject to the transi-
ent dynamics occurring shortly after intervention at dif-
ferent rates depending on transmission setting. The
relationships between outcomes with pre-intervention
EIR were generally sigmoid, with inflection points be-
tween two and 32 IBPAPA, depending on model variant
and outcome.
When LLINs were distributed to 63% of the human
population in mass distributions and augmented with
LLINs distributed to 72% of new-borns through neo-natal
services, the EIR was strongly reduced in the low trans-
mission settings. However, LLINs (only) reduced EIR by
about 75% in the highest transmission setting (256
IBPAPA) considered (Figure 5a). This may seem low in
comparison to, for instance, the 90% reduction observed
in an ITN trial [27] with 72.3% user adherence [28], where
annual EIR was estimated to be 237.25 – 288.35 IBPAPA,
by Beier and colleagues [29]. An important difference in
this simulation experiment is that mosquitoes were con-
sidered relatively resistant to pyrethoids (70% mortality in
a 0.05% deltamethrin WHO susceptibility test [16]),
whereas in the ITN trial, mosquitoes were fully suscep-
tible. Furthermore, in the simulation experiment, 25% of
the mosquitoes were assumed to be determined to bite
during times when net users would not be under their
nets [17]. With repeated long-term distributions, some re-
sistance (behavioural, physiological or metabolic) is likely
to develop and incorporating these settings in the central
scenario may be more reasonable than assuming fully sus-
ceptible and vulnerable mosquitoes, with which these
model variants simulate a much stronger reduction (than
90%) in EIR.
Below a pre-intervention EIR of 16 IBPAPA, the mean
periodic stable state was below the initial levels for both
number of episodes and DALYs (Figures 5d and 5g).
However, for a pre-intervention EIR of 32 IBPAPA and
above, the predicted mean number of episodes was higher
than for non-intervention scenarios and the number of
DALYs was higher than those in the non-intervention
scenarios for some model variants (Figure 5g).
Although the stable states are useful for summarizing
intervention effects, up to 60 years are required to reach
such a state. Thus, stable states are generally not consid-
ered by malaria control programme managers because
socio-economic developments and changes in the efficacy
of malaria control tools make them unlikely. A shorter
time horizon may be more relevant for public health deci-
sion making processes. Additional file 6: Figure S6.1 sum-
marizes the results averaged over 13 – 16 years from the




Figure 5 Impact of LLINs, CM or both on EIR, episodes and DALYs at periodic stable state. Ratios of results for intervention scenarios (a, d and g:
long lasting insecticidal nets (LLINs); b, e and h scaled up case management (CM); and c, f and i both LLINs and scaled-up CM) and non-intervention
scenarios (low CM only) calculated for means over the last 60 years of individual runs of 125 years, with 10 unique seeds per input EIR and model variant
combination, for outcomes a, b and c: entomological inoculation rate (EIR): d, e and f: episodes; and g, h and i: disability adjusted life years (DALYs). Lines
connect median values of groups of the ten seeds with the same input EIR and model variant. Model variants [12]: R0001 = solid black lines and circles;
R0063 = solid red lines and circles; R0065 = solid lime green lines and circles; R0068 = solid blue lines and circles; R0111 = solid cyan lines and circles;
R0115 = solid magenta lines and circles; R0121 = solid yellow lines and circles; R0125 = solid grey lines and circles; R0131 = dashed black lines and crosses;
R0132 = dashed red lines and crosses; R0133 = dashed lime green lines and crosses; R0670 = dashed blue lines and crosses; R0674 = dashed cyan lines
and crosses; R0678 = dashed magenta lines and crosses. Red polygons show ranges.
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time horizon, the relationships are very similar except that
the inflection points occur at somewhat higher pre-
intervention EIRs.
Under intervention in high transmission settings, the
mean periodic stable state of the burden could be higher
than the burden prior to intervention; this is a counter-
intuitive result that that can be explained as follows: At
equilibrium, the number of episodes in the population
reaches a maximum at intermediate transmission levels.
The relationship between transmission and malaria bur-
den in these modelsa is shown in Figure 6. The maximum
in the number of episodes occurs around an EIR of 16
IBPAPA for most model variants [12] (Figure 6a and 6d).
In a cross-sectional dataset comprising 10 sites, Marshand Snow [11] show that severe malaria disease in chil-
dren reaches a maximum at roughly 15% parasite preva-
lence. Their dataset was assembled prior to large scale
LLIN intervention, thus it may be presumed that the sites
included were also more or less in equilibrium at the time
of measurement. Presenting cross-sectional data from
Brazaville, Trape and Rogier [30] also show a similar peak
in the relationship between burden and transmission. The
observation of such maxima at intermediate transmission
levels led the scientific community to speculate that as
transmission reduces from high to intermediate levels, the
malaria burden might increase. Ideally, such a hypothesis
would be tested with longitudinal datasets in locations
where increased vector control reduces transmission grad-
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Figure 6 Episodes, deaths, and DALYs depending on transmission and CM without LLINs. Averages for the last 60 years of individual runs
of 125 years, with 10 unique seeds per input EIR and model variant combination, with a & d) episodes per person per year b & e) direct and
indirect deaths due to malaria, and c & f) disability adjusted life years (DALYs). Lines connect median values of groups of the ten seeds with the
same input EIR and model variant. See the legend of Figure 5 for model variant [12] colour coding.
Briët and Penny Malaria Journal 2013, 12:401 Page 9 of 19
http://www.malariajournal.com/content/12/1/401coverage and effectiveness are constant. However, such lo-
cations are hard to find. Although vector control has in-
creased since the year 2000 in most of sub-Saharan Africa,
CM has changed as well, switching from chloroquine to
sulfadoxine-pyrimethamine (SP) to artemisinin com-
bination therapies (ACTs) as first line treatment, due to
developing drug resistance. For instance, O’Meara and col-
leagues [31] did not observe an increasing malaria burden
as parasite prevalence fell in Kilifi district, Kenya over the
period 1990 – 2007, but the reduction in parasite preva-
lence after 1998 could be due to the switch to SP that year.
The EIR in the area was, on average, 19.3 IBPAPA in
1997–1998 [32], although with strong spatial variation and
thus perhaps too low to expect an increase in disease
along with decreasing exposure.
A possible explanation for why transmission and malaria
burden peak at intermediate EIR levels is that at (very)
high EIR levels, people are quickly immunized and pro-
tected against severe disease by on-going immunity-maintaining infections. In these models, simulations with
a weaker seasonality showed the peak number of episodes
occurring at a lower EIR, probably because the immunity-
maintaining infections are more evenly spread throughout
the year (Stuckey, unpublished observations). However, there
is some controversy over whether or not this phenomenon
of a peak burden at intermediate EIR really exists. Problems
with using cross-sectional data, due to confounders such as
seasonality and innate immunity, have been pointed out
[33-37]. The dataset of Marsh and Snow [11] was used,
among others, to fit these models [38]. In order to investi-
gate the sensitivity of this phenomenon to this cross sec-
tional dataset, one model variant was refitted excluding
the Marsh and Snow dataset [11]. Without the Marsh and
Snow dataset [11], the relationship between EIR and total
number of episodes was similar to that with the data set
included [Additional file 7]. The relationship between EIR
and DALYs was also similar but somewhat steeper than
with the data included and the impact of LLINs still had

































Figure 7 Mean NHBs of LLINs and CM at periodic stable state.
Lines are goodness of fit-weighted averages of the 14-variant model
ensemble, averaged over the last 60 years of the 125 year simulation
period, where the net health benefits (NHB) are in a periodic stable
state. NHB are calculated as compared to scenarios with a low base-
line case management (CM) of 9% reported treatment of recalled fe-
vers with an effective antimalarial drug in DHS type surveys. The red
line shows the effect of only distributing LLINs. The green line shows
the effect of only scaling up CM to 80% reported treatment of
recalled fevers. The black line shows the effect of both distributing
LLINs and scaling up CM to 80%. The grey dashed line is the sum of
the red and green line.
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fitting these dynamic malaria models to data on ‘preva-
lence with age’ alone results in similar dynamics. This was
also demonstrated in another malaria model [39,40].
At high transmission intensity, malarial disease is
mostly concentrated among the youngest age groups. As
transmission intensity decreases, malarial disease con-
centration shifts from the youngest age groups and
spreads more evenly over all age groups, possibly leading
to relatively more cerebral malaria and higher case fatal-
ities at intermediate transmission levels [11,30]. Many mal-
ariological studies limit themselves to examining malaria
in children under ten [11] or under five years of age [37],
partly because the duration of immunity is poorly under-
stood and because the high malaria burden in children
makes this group one of special interest to malaria control
programme planners. For this reason, the graphical ana-
lyses in this manuscript were repeated for children under
five years of age only [see Additional file 3]. However, ana-
lyses for the whole population are preferred as the analyses
for children under five do not capture the shifts of morbid-
ity and mortality to older age groups and because DALYs
already give deaths occurring at young ages more weight
as a result of more years of life lost (YLLs).
The similarity between Figure 5b and 5e illustrates that,
in scenarios with scaled-up CM as a single intervention,
most of the reduction in episodes in low transmission
settings was due to sustainably reduced transmission. At
higher transmission settings, the reduction in absolute
DALYs was due to fewer uncomplicated cases progressing
into severe disease and death. The combination of both
LLIN distribution and scaled-up CM reduced EIR more
than LLIN distribution alone could achieve in pre-
intervention transmission settings with between eight and
16 IBPAPA (Figure 5c), but did not reduce EIR much in
higher transmission settings beyond 32 IBPAPA. This ex-
plains the curves in Figure 5f in comparison to Figure 5d.
Similarly, this joint effect on transmission is one of the
factors that explain the difference between Figure 5i and
Figure 5g at intermediate pre-intervention EIR level.
The general reduction in intermediate and high pre-
intervention EIR settings due to scaled-up CM (Figure 5h)
is another explanatory factor. Further, the difference in
how the combined intervention affects DALYs as com-
pared to LLIN intervention alone may be because of the
altered relationship between transmission and disease bur-
den due to CM. Panels d, e and f in Figure 6 show how
disease burden relates to transmission at the higher CM
level in the OpenMalaria models. For episodes, the plots
are very similar to those from the low CM level situation.
For deaths and DALYs, however, maxima at intermediate
transmission levels were somewhat less pronounced at the
high CM level compared to at the low CM level and the
point at which malaria burden is highest shifted to ahigher transmission level, if it occurred at all. CM thus al-
ters the relationship between transmission and severe dis-
ease and allows transmission reducing LLINs to be more
effective in decreasing malaria burden.
Figure 7 allows for a direct comparison of the effects
of individual (sustained LLIN distribution or scaled-up
CM) and combined interventions, by showing the mean
NHB of these interventions for the periodic stable state
(the last 60 years of the 125-year simulation period) to-
gether in a single plotb. In low pre-intervention EIR set-
tings, both LLINs and CM each had high NHB, but in
combination they could not achieve more than what each
intervention could achieve by itself because, in these low
settings, malaria was prevented largely by either inter-
vention. The NHB of either intervention was higher at a
pre-intervention EIR of two IBPAPA than at one IBPAPA
because there is more malaria to avert at the higher trans-
mission setting. For the combined intervention, NHB con-
tinued to increase with increasing pre-intervention EIR,
up to eight IBPAPA. However, for individual interventions,
NHB declined in pre-intervention transmission settings
above two IBPAPA, even though the preventable disease
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Figure 8 NHBs of LLINs depending on CM and distribution rate.
Lines are goodness of fit-weighted averages of the 14 variant model
ensemble, averaged over the last 60 years of the 125 year simulations.
Green, blue and red lines represent scenarios where mass distributions
were done every three, four and five years, respectively. a) Case man-
agement (CM) level of 9% reported treatment of recalled fevers with
an effective antimalarial drug DHS type surveys. b) CM level of 59%. c)
CM level of 80%.
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http://www.malariajournal.com/content/12/1/401eight IBPAPA (Figure 6c). Thus, the decline in NHB for
individual interventions between pre-intervention trans-
mission settings of two and eight IBPAPA is presumably
due to the increase in residual transmission (Figures 5a
and 5b), which only becomes important for the combined
intervention above eight IBPAPA (Figure 5c). The increase
in residual transmission was strongest between four and
16 IBPAPA for individual interventions (Figures 5a and
5b) and between 16 and 64 IBPAPA for the combined
intervention (Figure 5c), reflected in the steep declines in
NHB with increasing pre-intervention EIR over these in-
tervals (Figure 7). As a result, in intermediate transmission
settings (e.g. an EIR of 16 IBPAPA), the combined inter-
vention achieved much higher NHB than the sum of the
effects of each individual intervention. The altered shape
of the relationship between transmission and disease bur-
den due to scaled-up CM plays only a minor role. Above
an EIR of 64 IBPAPA, the combination was less cost-
effective than CM alone. This is because above 64
IBPAPA, the average of model variants predicted that the
burden would increase as EIR decreases at this high level
of CM (Figure 6f).
Additional file 6: Figure S6.2 summarizes the NHB of
the fourth LLIN distribution round. With a much a
shorter time horizon, for an LLIN single intervention,
the curve is slightly higher and shifted to the right,
breaking the ‘zero NHB’ line at 32 IBPAPA instead of at
24 IBPAPA as at the stable state. For scaled-up CM, the
relationship is very similar and for the combined inter-
vention, the curve is nearly identical to the curve at the
stable state.
Figure 8 shows the mean NHB of LLINs, depending on
the transmission levelc prior to LLIN intervention and on
distribution rate (mass distributions at intervals of three,
four or five years) at the periodic stable state, for three
levels of CM. With increasing CM levels, the maxima in
the curves for NHB of LLINs shift to higher transmission
levels and diminish slightly. In a situation with a low CM
level, NHB of LLINs were negative above about 20
IBPAPA. With a high CM level, this was above about 56
IBPAPA. It should be noted that NHB were predicted to
be negative for LLINs at higher pre-intervention EIR be-
cause DALYs themselves were negative, not because the
costs were high. This result was relatively insensitive to
the choice of ceiling ratio at USD 235.28 per DALY. With
a higher ceiling ratio of, for example USD 1000 per DALY,
the values would still have been negative. With a lower
ceiling ratio (e.g. USD 100 per DALY), the values would
have been more negative.
In settings with an intermediate EIR level prior to
LLIN intervention, a higher distribution frequency was
predicted to be more cost-effective. However, in the
highest transmission settings, where predicted NHB of
LLINs were negative, increasing the distribution ratemade LLINs slightly less cost-effective. Also, with the
highest CM level, in the lowest transmission setting
simulated (less than 0.0625 IBPAPA), a higher distribu-
tion frequency was marginally less cost-effective. At this
high CM level of 80% reported treatment of recalled fe-
vers, varying distribution intervals (between three
and five years) has surprisingly little impact on cost-
effectiveness of LLINs for settings between one eighth
and four IBPAPA prior to LLIN intervention, the extra
costs being balanced out by slightly higher burden
reductions.
In addition to examining the sensitivity of NHB of
LLINs to transmission setting, CM level and LLIN mass
distribution frequency, the sensitivity of NHB to mosquito
susceptibility to pyrethroids, LLIN attrition half-life, popu-
lation coverage of LLIN mass distributions and target
population coverage in continuous distribution
Briët and Penny Malaria Journal 2013, 12:401 Page 12 of 19
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the results of this sensitivity analysis for individual model
variants around the central scenario, expressed in DALYs,
with CM kept at the low baseline. Additional file 8: Figure
S8.1a is comparable to the red line for LLINs in Figure 7,
except that it shows results for each model variant sep-
arately, rather than a weighted average. At a pre-
intervention EIR of 16 IBPAPA [Additional file 8: Figure
S8.1], all model variants but four (R0115, R0125, R0132,
R0133) predicted positive NHB for the central scenario.
For transmission levels below eight IBPAPA, all model
variants predicted positive health benefits, whereas for
transmission levels above 32 IBPAPA, most variants pre-
dicted negative NHB.
The NHB of LLINs were very sensitive to the susceptibil-
ity of the mosquito population to pyrethroids [Additional
file 8: Figure S8.1b] (although less sensitive than to the
pre-intervention EIR), illustrating the threat of insecticide
resistance to the sustainability of health benefits from
LLIN distributions. The NHB were relatively insensitive
to variations in attrition half-life [Additional file 8:
Figure S8.1c], population coverage of LLIN mass distri-
butions [Additional file 8: Figure S8.1e] and target
population coverage of continuous distribution prog-
rammes [Additional file 8: Figure S8.1f], as well as to vari-
ations in mass distribution round intervals [Additional file
8: Figure S8.1d]. At a pre-intervention EIR of four IBPAPA
[Additional file 8: Figure S8.2], where LLINs showed high
cost-effectiveness for all model variants, sensitivity to
pyrethroid susceptibility and LLIN distribution parameters
was similar to the sensitivity at a pre-intervention EIR of
16 IBPAPA.
In general, where LLINs had positive NHB, NHB im-
proved slightly with increasing coverage and distribution
frequency for the ranges studied, despite the higher cost
associated with higher LLIN distribution rates. This is
because the differences in costs, expressed in DALYs, were
insignificant compared to the difference in DALYs averted.
For instance, the difference in cost between five-year
round intervals of three-year intervals was a mere USD
0.28 per person per year, equivalent to 0.00176 DALYs at a
ceiling ratio of USD 235.28 per DALY. This cost difference
is further reduced by health systems cost savings due to
fewer treatments at higher distribution rates.
The model variants showed large variations in the pre-
dicted effects of LLINs on the mean periodic stable state
burden levels (Figure 5), as well as in sensitivities of LLIN
NHB to aspects of the vector population, LLIN quality
and distribution rate [Additional file 8: Figures S8.1 and
S8.2]. These observations can be linked to strong varia-
tions in the impact of LLINs on transmission (Figure 5a,
[see also Additional file 9]) and to the shape of the
relationships between deaths, DALYs and transmission
(Figure 6b and 6c). In Figure 6, some model variants(R0063, R0065, R0068) show a sharp peak between eight
and 16 IBPAPA. One variant (R0115) shows a sharp peak
around one IBPAPA, but for the other 10 variants, the re-
lationships are increasing or relatively flat moving from
low to high transmission. The strong differences among
model variants in the relationship between transmission
and disease burden reflect uncertainty about this relation-
ship; the ensemble of variants encompasses a range of as-
sumptions about malaria epidemiology and these were
individually fit to malariological data sets. This dubious-
ness translates into uncertainty about the sensitivity of
NHB to intervention scenarios.
Dynamics of malaria after halting LLIN distribution
In a subset of scenarios, LLIN distribution was halted
abruptly after 32 years of distribution (in eight rounds at
four-year intervals, as well as continuously through
ante-natal services). In some of these scenarios, CM was
scaled up five years into the simulation and kept con-
stant thereafter (even if LLIN distribution was halted).
Figures 9 and 10 show the simulated malaria dynamics
over time for a setting with low CM and scaled-up CM, re-
spectively. After halting LLIN distribution (the last LLINs
were distributed 37 years into the simulation), malaria in-
creased rapidly to a level above the pre-intervention level
and then declined slowly to the pre-intervention level. The
maxima of these ‘rebounds’ were particularly high in the
lower pre-intervention transmission settings. For instance,
in a setting with a pre-intervention EIR of four IBPAPA,
up to three times as many DALYs as in the pre-
intervention stage were observed temporarily (Figure 9i
and Figure 11c). In settings with 64 or more IBPAPA
pre-intervention, the rebounds were relatively small,
particularly for episodes and DALYs. However, a com-
parison between Figure 5g and Figure 11c shows that
there is no linear relationship between the magnitude of
the long-term reduction and the rebound maximum:
the rebound maximum for DALYs was highest at pre-
intervention EIRs of between four and eight IBPAPA,
depending on the model variant, whereas the relative
long-term reduction in malaria DALYs was intermediate
in these transmission settings.
In situations where CM was scaled up at the same time
as the first LLIN distribution and where CM was main-
tained at a high level, rebounds to above pre-intervention
levels did not always occur (Figure 11d – f). For instance,
in a setting with a pre-intervention EIR of below four
IBPAPA, malaria increased gradually over time until it
reached a new stable state, which was below the pre-
intervention level (Figure 10). In settings with 64 or more
IBPAPA pre-intervention, EIR and malaria episode dy-
namics were very similar to those for situations without
scaled-up CM, although scaled-up CM maintained a lower
level of DALYs (Figures 9 and 10). At intermediate pre-
Figure 9 Impact of halting LLIN distribution on EIR, episodes and DALYs for a central scenario over time. a – d) entomological
inoculation rate (EIR), e – g) episodes and i – l) disability adjusted life years (DALYs). Rows of panels have the same pre-intervention EIR.
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http://www.malariajournal.com/content/12/1/401intervention EIR settings between four and 64 IBPAPA,
with continued scaled-up CM, rebound maxima after halt-
ing LLIN distribution were still present, though mitigated
and the size of these maxima varied strongly depending
on the model variant. Note that in Figure 11d – f, the re-
bound maximum ratios are calculated in comparison to
the non-intervention scenario with low CM. Thus, the
rebound maximum ratios resulting from halting LLIN
distribution, compared to scenarios with continued high
CM (with lower malaria burden), would be stronger
[see Additional file 10].Relative importance of transmission settings
The 2010 distribution of the African population living in
malaria endemic zones over the range of Plasmodium
falciparum transmissions is shown in Figure 12. Such a
figure could be helpful to quantify the prevalence of the
different transmission settings in Africa and, thus, to as-
sess the importance of the transmission-setting dependent
findings. It should be noted that a pre-intervention distri-
bution would be better suited to this study, since in 2010,
the strong reduction in transmission in many African
countries was likely due to the scaling up of LLINs. A pre-
Figure 10 Impact of halting LLIN distribution on EIR, episodes and DALYs with continued scaled-up CM. a – d) entomological inoculation
rate (EIR), e – g) episodes and i – l) disability adjusted life years (DALYs). Rows of panels have the same pre-intervention EIR.
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shape to Figure 12, but be shifted towards higher trans-
mission. At the time of writing, the Malaria Atlas Project
is planning to produce a ‘pre-intervention’ transmission P.
falciparum map that would exclude data points where
malaria is likely affected by interventions (Gething, per-
sonal communication).
By comparing Figures 7 and 11 to Figure 12 (and as-
suming that the shift would be negligible), the following
could be predicted: for a large proportion of the Africanpopulation (about 60%) residing in areas with a lower
range of transmission below about two IBPAPA, either
sustained high levels of CM or sustained LLIN distribu-
tions would be cost-effective; a combination of the two
interventions would have only marginally more NHB.
However, a morbidity rebound (apparent as an epidemic)
is unlikely to occur if LLIN distribution is halted while
CM continues. For an additional 30% of the population,
exposed to higher transmission up to about 64 IBPAPA,
LLINs must be combined with CM in order to be most
ba c
ed f
Figure 11 Maximum rebound after abruptly halting LLIN distributions, depending on CM and pre-intervention EIR. Maxima in the ratios
of results after halting LLIN distribution after eight rounds (with a, b and c: low baseline CM and d, e and f scaled-up CM); and non-intervention
scenarios (low CM only) calculated for means over the last 60 years of individual runs of 125 years, with 10 unique seeds per input EIR and model
variant combination, for outcomes a and d: entomological inoculation rate (EIR): b, and e: episodes; and c and f: disability adjusted life years
(DALYs). Lines connect median values of groups of the ten seeds with the same input EIR and model variant. See the legend of Figure 5 for
model variant [12] colour coding. Red polygons show ranges. Note that if the rebound maximum is shown is below 1.0, it is possible that the
maximum is not reached within 23 years post halting of LLIN distribution, and it is likely that in that case, the maximum is not larger than 1.0.
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http://www.malariajournal.com/content/12/1/401cost-effective, due to a synergistic effect. For this seg-
ment of the population, halting LLIN distribution
abruptly (after a period of implementation) even while
continuing high level CM could result in major epi-
demics, with peaks in episodes and DALYs up to two
times those in the pre-intervention level. For the
remaining 10% of the population, exposed to high trans-
mission, scaling up and sustaining a high level of CM
would be the best strategy for reducing the disease bur-
den, as LLINs would not increase NHB. Somewhatsurprisingly, halting LLIN distributions abruptly while
continuing CM may not result in major epidemics in
this segment of the population.
Conclusions
Because of increasing concerns about how to sustain the
gains of recent malaria control successes with LLINs and
CM, this study simulated malaria in scenarios with sus-
tained or abruptly halted LLIN distributions, with or with-
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Figure 12 Distribution of the African population over the
transmission spectrum as of 2010. a) Density and b) cumulative
density. The distribution is calculated from the ‘PfEIR’ map published
by Gething and colleagues [41].
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http://www.malariajournal.com/content/12/1/401in the short term, LLIN distributions are very beneficial
over the entire spectrum of transmission settings, reducing
both transmission and disease burden. However, the longer-
term dynamics indicated that, under sustained vector con-
trol, transmission and burden rebound to higher levels than
those initially reached, with the level of the periodic stable
state and the time needed to reach that stable state depend-
ing on the pre-intervention level of transmission.
In low to medium pre-intervention transmission set-
tings (up to about 16 IBPAPA), immunity acquisition
was reduced in simulation scenarios with sustained
LLIN distribution and, as a result, malaria transmissionand malaria disease burden increased over several de-
cades until new stable states were reached, below the
level prior to intervention. This increase happened while
pyrethroid susceptibility of vector mosquitoes was con-
sidered constant. With evidence of building pyrethroid
resistance [42] and high sensitivity of LLIN effectiveness
to pyrethroid susceptibility in the simulation results, the
estimated increases (rebounds) in disease burden are
probably conservative.
In higher transmission settings, sustained distribution of
LLINs resulted in transmission levels that stabilized at
levels lower than those at pre-intervention. Whereas the
new transmission level was lower than at pre-intervention,
simulation results predicted that the disease burden could
potentially be above pre-intervention levels in previously
high transmission settings if transmission was not reduced
sufficiently. As discussed by Marsh and Snow [11], the
non-linear relationship between transmission and burden
dictates that if transmission is decreased from a high to a
medium level (but not much further), the burden might in-
crease in the long term as immunity acquisition is reduced.
To mitigate the potential for increased disease burden,
Marsh and Snow [11] propose increasing the focus on CM.
Some scientists may doubt the validity of Marsh and Snow’s
[11] data and may argue that using their data to
parameterize the models may force the observed negative
NHB of LLINs at high EIRs. However, OpenMalaria models
and other models [39,40] that did not include this dataset
showed similar results; this is likely due to fitting the
models to data on the relationship of parasite prevalence or
parasite density with age.
Analysing the level of the stable state revealed a strong
interaction between CM and LLINs on NHB. The direction
of this interaction depended on the pre-intervention trans-
mission setting. The interaction can be explained by both
joint effects on transmission (reducing transmission below
the intermediate transmission level) and CM altering the
relationship between transmission and burden. Improved
CM coverage rendered LLINs more cost-effective at higher
transmission settings than without improved CM coverage.
This indicates that in areas with medium transmission in-
tensity, integrated control [11,43] will be highly cost-
effective. However, in settings with a (very) high pre-
intervention transmission level (roughlyd, above 64
IBPAPA), the combination of both LLINs and improved
CM was less cost-effective than CM alone in scenarios with
sustained (very) high CM combined with sustained LLIN
distribution and with no changes in LLIN efficacy nor in
the malaria control programme. Thus, the results indicate
that with a long-term perspective, distributing LLINs might
not be cost-effective in areas [44] with such high transmis-
sion. This conclusion should be balanced with the know-
ledge that 90% of the population in African most likely lives
in areas with much lower (potential) transmission.
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relatively small compared to the effects of transmission set-
ting. The magnitude of the effects, however, was sensitive
to transmission setting. Planning for optimal combinations
of malaria control tools will need to take into account both
the pre-intervention potential for transmission and existing
CM levels and will thus need to be geographically specific.
However, there is considerable uncertainty about these
levels and a lack of information on the (probably) consider-
able short-range spatial heterogeneity, limiting the mean-
ingful spatial resolution of such plans.
Simulation results indicate that after a period of vector
control, abruptly halting LLIN distribution can result in
major epidemics with peaks in episode counts and DALYs
up to three times the pre-intervention level. This is a result
of reduced levels of acquired immunity in the population,
while the vector population recovers quickly to the pre-
intervention level. Roughly 90% of the population in Africa
lives in settings with a transmission below 64 IBPAPA prior
to intervention and are most at risk of such large epidemics;
epidemics would be less severe in areas with a transmission
above 64 IBPAPA prior to intervention. Continuing a high
level of CM could somewhat mitigate these epidemics.
The analysis presented here was repeated for children
under five years of age only [Additional file 3]. In this ana-
lysis, the pre-intervention EIR up to which LLINs are
cost-effective is four- to ten-fold higher than in the ana-
lysis for the entire population and rebounds after halting
distributions are much less severe. This is because in chil-
dren, acquired immunity is less important than it is for
older people, simply because children have been exposed
for a shorter period of time and thus have acquired less
immunity. Analyses that ignore older age groups [37]
could seriously underestimate the implications of waning
immunity in the population described here.
Even though more data is becoming available on the
temporal dynamics of malaria in specific settings with an
increasing history of LLIN distribution [45,46], fitting
these malaria models to such temporal data as a means
of model validation remains a challenge, with continu-
ously evolving mosquitoes, parasites, therapeutic drug
regimens, access to treatment, etc. influencing the tem-
poral dynamics.
This study indicated that scaling up and maintaining
high levels of access to effective care can preserve the
cost-effectiveness of LLINs in higher transmission set-
tings. Although this simulation study looked only at
combinations of CM and LLINs, high levels of access to
effective care will be important for mitigating potential
rebounds in disease burden occurring after initial suc-
cesses of transmission reducing interventions. However,
in the face of developing drug-resistance and increasing
influx of counterfeit drugs, scaling up and maintaining
access to effective care may be challenging.Endnotes
a It is worth noting that, because of the importation rate
of 10 infections per 1000 people per year into the popula-
tion (included in the scenario in order to simulate im-
portation from neighbouring areas and in order to
prevent malaria from becoming extinct for stochastic
reasons at low transmission levels), with low CM, it
was difficult to simulate transmission settings below
0.0625 IBPAPA. With a lower infection importation
rate, lower transmission settings could be simulated
[Additional file 11].
b Note that, in contrast to Figure 5, where outcome
variables are shown as a ratio of the results in the non-
intervention scenarios, Figure 7 shows results in terms
of an absolute difference. Whereas in Figures 5, a
curve is below the line where ‘ratio equals unity’ indi-
cates a desired effect, in Figure 7, a curve above the
horizontal line of ‘zero NHB’ indicates a desired effect.
Also, instead of lines for each of the 14 model variants,
a goodness of fit-weighted average of the model
ensemble is plotted.
c Note that, in contrast to the black line in Figure 7,
these plots are for the NHB of LLINs only and the trans-
mission level on the horizontal axis is the one obtained
with CM.
d In many African settings, LLIN effectiveness may be
different from the effectiveness assumed in this model-
ling study and the pre-intervention EIR below which
LLINs become cost-effective may be different due to dif-
ferences in mosquito host seeking parameters, seasonal-
ity, and other parameters used. Also, even though the
80% reported treatment of recalled fevers is lower than
the Roll Back Malaria (RBM) 2010 target, it is still much
higher than levels currently being achieved across Africa
[47]. Given obstacles to care seeking and ACT access
[48,49], such high CM coverage levels might not be real-
istically achievable in many countries in the near future.
Therefore, the exact EIR indicated by these simulation
results as the point where LLINs might have negative
NHB may not be true in reality.Additional files
Additional file 1: ICERs of LLINs and scaled-up CM.
Additional file 2: Central scenario.
Additional file 3: Figures for children under five years of age.
Additional file 4: Infectiousness of the human population to
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